Trends of recanalization therapies and state of art for ischemic stroke treatment in Campania region, Italy

Neurol Sci. 2022 Dec;43(12):6865-6870. doi: 10.1007/s10072-022-06321-3. Epub 2022 Sep 8.

Abstract

Background: According to the last Italian report by the Ministry of Health in 2018, the estimated number of acute ischemic strokes (AIS) in Campania is 10,000/year, with an expected number of 1390 intravenous thrombolysis (IVT) and 694 mechanical thrombectomies (MT). In 2017, only 1.5% of expected patients received IVT and 0.2% MT. This study analyzed the trend of IVT and MT in 2019-2020 and depicted the state of art of Stroke Care in Campania.

Methods: From the regional health task force, we obtained the hospital discharge forms from all private and public hospitals in Campania; we selected patients with a principal diagnosis of AIS and measured the rate of patients admitted to neurology units and the rate of IVT, MT, and IVT + MT for both 2019 and 2020.

Results: In 2019, we observed 4817 admissions for AIS; 2858/4817 (59.3%) patients were admitted to neurology units. Out of 4817 patients, 192 received IVT, 165 MT, and 131 IVT + MT (488 treated patients; 10.1%). In 2020, we observed 4129 admissions for AIS; 2502/4129 (62.7%) patients were admitted to neurology units. Out of 4129 patients, 198 received IVT, 250 MT, and 180 IVT + MT (628 treated patients; 15.2%). These results showed that despite a reduction of AIS admissions in 2020, the relative and absolute rate of recanalization treatments increased. However, the number of patients who were not admitted to neurology units nor received acute treatments remained dramatically high.

Conclusion: Despite the development of acute treatments, the Campania Stroke Network still needs significative efforts to improve.

Keywords: Campania; Epidemiology; Recanalization therapies; Stroke; Trend.

MeSH terms

  • Brain Ischemia* / drug therapy
  • Brain Ischemia* / therapy
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Ischemic Stroke*
  • Stroke* / drug therapy
  • Stroke* / therapy
  • Thrombectomy / adverse effects
  • Thrombolytic Therapy / methods
  • Treatment Outcome

Substances

  • Fibrinolytic Agents